Stock Ratings / Health Care / SNDL / dividends

CGC (41) OBIO (36) USNA (50) TLRY (20) ⌘ Pro Terminal →

SNDL Inc. (SNDL) Dividend Safety Gauge & 10-Year DRIP Compounder

$1.24 -4.61% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.23

SNDL Inc. (SNDL) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D • SELL / AVOID Cap $316.3M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on SNDL Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is SNDL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, SNDL Inc. (NASDAQ: SNDL) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $1.24 (-4.61% 1D, market cap $316.3M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, SNDL ranks #325 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does SNDL compare to CGC and OBIO in the Health Care sector?

▼

Within the Health Care sector (Medicinal Chemicals and Botanical Products), SNDL carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, CGC (Canopy Growth Corporation) holds a D- grade (41/100 RQD, P/E N/A, ROIC —, cap $285.6M) and OBIO (Orchestra BioMed Holdings Inc.) posts a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $366.0M). Among the 5-stock peer group, USNA leads on earnings multiple (24.6x) while USNA leads on capital efficiency (7.9% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for SNDL?

▼

For SNDL Inc. (SNDL), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #325 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.23 (-1.02%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0.2% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.6% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-4.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SNDL)Realized 20D OHLCV Swing Band: ±8.3%

Deterministic 5-Pillar Attribution (48/100 Composite)

🔍 WHY SNDL SCORES 48/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (27% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+12/20 pts (25% of score)

SEC XBRL Trailing 12 Months: 0.2% FCF Margin ($8.9M FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning6/20 pts (-14 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-14 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$1.17+6.8% Next Q

Q2 (-2Q)

Grade D$1.25+1.6% Next Q

Q3 (-1Q)

Grade D$1.27-2.4% Next Q

Current

Grade D$1.24-5.6% Hist 90D α

Trajectory: D (40) → D (48)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a SNDL Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While SNDL currently carries a cautious 48/100 (D) rating due to Whale & Options Positioning (6/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.32) and Max Pain ($1.30) forces dealer call-delta covering toward $2.46.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $SNDL• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “SNDL Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 48%NO 52%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (6.8% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $19,307

Est. Year-10 Shareholder Yield: $348/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.7K

Yr 1

$11.4K

Yr 2

$12.2K

Yr 3

$13.0K

Yr 4

$13.9K

Yr 5

$14.8K

Yr 6

$15.8K

Yr 7

$16.9K

Yr 8

$18.1K

Yr 9

$19.3K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SNDL)

✓Walkthrough of SNDL's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

SNDL // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -12.68%▼ DESCENDING CHANNEL

2026-11-02O $1.29H $1.30L $1.24C $1.24VOL 1.08M

RES: $1.44SUP: $1.12SMA50: $1.32SMA200: $1.39

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SNDL Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 SNDL Butterfly Map → + Track SNDL →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on SNDL today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for SNDL. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for SNDL today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SNDL)

Health Care Rank #325 of 1016 ⚔️ CGC vs SNDL Full Matrix →

1. Head-to-Head Health Care Peer Comparison (SNDL vs. CGC, OBIO, USNA, TLRY)

Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, SNDL Inc. (SNDL) ranks #325 by composite RQD confidence (48/100, grade D) and #515 by equity capitalization ($316.3M). Within this direct 5-issuer industry benchmark cohort, USNA leads on earnings valuation at 24.6x trailing P/E, while USNA leads on capital efficiency and profitability with 7.9% ROIC and 78.3% gross margin. USNA currently holds the highest overall quantitative score in the immediate peer group at 50/100 (D) compared with SNDL at 48/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
SNDL ACTIVE SNDL Inc.	D	48/100	—	—	—	-4.61%	$316.3M	Benchmark Subject
CGC Canopy Growth Corporation	D-	41/100	—	—	—	-3.33%	$285.6M	/cgc-vs-sndl →
OBIO Orchestra BioMed Holdings Inc.	D-	36/100	—	96.0%	-35.0%	-2.96%	$366.0M	/obio-vs-sndl →
USNA USANA Health Sciences Inc.	D	50/100	24.6x	78.3%	7.9%	-0.21%	$265.0M	/usna-vs-sndl →
TLRY Tilray Brands Inc.	E	20/100	—	28.4%	-3.9%	-4.17%	$390.2M	/tlry-vs-sndl →

2. SNDL Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

SNDL Inc. (SNDL) operates in Medicinal Chemicals and Botanical Products (Health Care) with an equity capitalization of $316.3M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. SNDL Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is SNDL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does SNDL compare to CGC and OBIO in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for SNDL?

Where is SNDL trading relative to its 50-day, 200-day, and 52-week technical levels?

SNDL last traded at $1.24 (-4.61% on volume of 1,385,411 shares), positioning the stock -6.06% below its 50-day simple moving average ($1.32) and -10.79% below its 200-day simple moving average ($1.39). Across its 52-week range of $1.13 to $2.34, SNDL sits at the 9.1% percentile with a 14-day RSI of 53.4 (NEUTRAL RANGE) and an implied next-earnings move of ±8.3% ($1.14 to $1.34).

SNDL Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does SNDL pay a dividend and is it safe?

SNDL Inc. (SNDL) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: SNDL RQD Cockpit SNDL 12M Forecast SNDL Earnings & Move SNDL Dividends & DRIP SNDL Insiders & 13F SNDL Whale Options SNDL Profit Sankey SNDL News & Why

ROARABLE RATING BRIEF • RQD 48/100 (D) ✓ STAGE-C NUMBER FIREWALL VERIFIED

SNDL — SNDL Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T14:16:45Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, SNDL scores 48 out of 100, a letter grade of D, with the verdict "Roarable Sell — Underperform / Distribution Warning." The five pillars are: Fundamental Cash Engine at 12 / 20 (ROIC 0%; FCF yield 0%), Whale 13F Flow at 6 / 20 (institutional accumulation and options positioning), Insider Conviction at 9 / 20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 8 / 20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet at 13 / 20 (Altman Z 2.5; Piotroski F 6/9; Debt/Equity 0.5).

For a prospective investor, the weakest pillars are the cash engine and the institutional and insider flow pillars, which together signal that the source data shows no measurable return on invested capital or free cash flow yield, and only limited evidence of institutional or insider conviction. The forensic balance sheet pillar is the strongest relative to the rest, with an Altman Z of 2.5 and a Piotroski F of 6/9, which the rating treats as moderate rather than distressed. Upside drivers would need to come from a change in cash generation, since the rating's valuation context is constrained by the absence of earnings-based multiples in the source data. The 2nd-order implication is that the current price of 1.3 sits within a 52-week range of $1.13 - $2.34, so the stock is trading in the lower portion of its recent band while the rating remains in distribution-warning territory.

Recent Catalysts & News Wire Analysis

Yahoo Finance (YELLOW, Market Wire) headlined a Q3 earnings cash flow question for SNDL.
Seeking Alpha (YELLOW, Market Wire) headlined short-term issues following Q3 earnings.
The Globe and Mail (GREEN, Catalyst) reported record Q3 free cash flow and expanded capital returns after shareholders rejected a consolidation.
Stock Titan (GREEN, Catalyst) noted a possible buyback that would cap the price 17.4% above the October 14 close.
Mugglehead Investment Magazine (YELLOW, Market Wire) reported that director Carlo Cannell resigned without a named successor.
Butterfly Supply-Chain Graph: supply_chain is NONE, with no butterfly links and no proprietary signals.

The tension in the news flow is between a GREEN record-free-cash-flow catalyst and a YELLOW earnings question, alongside a board resignation. The rating's 0% FCF yield sits uneasily beside the reported record free cash flow, and the source data does not reconcile the two.

Open Questions

What are the reported revenue, operating income, net income, and free cash flow figures for recent periods, given that the financials section is empty?
Why does the RQD rating show 0% ROIC and 0% FCF yield while news reports record Q3 free cash flow?
What are the P/E, forward P/E, and EV/EBITDA multiples, given that they are not available in source data?
Who are the institutional and insider holders, and what is the direction of their recent activity?
What is the status of the proposed buyback and the director resignation, and who may succeed the director?

SNDL Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for SNDL Inc. (SNDL) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to SNDL Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 41m ago

SNDL (NasdaqCM:SNDL) Stock Faces A Q3 Earnings Cash Flow Puzzle

Yahoo Finance report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Seeking Alpha • 3h ago

SNDL: Q3 Earnings Reveal Short-Term Issues (NASDAQ:SNDL)

Seeking Alpha report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance UK • 6h ago

SNDL Inc. (SNDL) stock price, news, quote and history

Yahoo Finance UK report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST The Globe and Mail • 9h ago

SNDL Reports Record Q3 Free Cash Flow, Ramps Up Capital Returns After Shareholders Reject Consolidation

The Globe and Mail report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Stock Titan • 12h ago

A possible buyback at SNDL (SNDL) would cap its price 17.4% above the October 14 close.

Stock Titan report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Mugglehead Investment Magazine • 15h ago

SNDL Inc.'s director Carlo Cannell resigns without named successor

Mugglehead Investment Magazine report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE GuruFocus • 18h ago

SNDL Inc. Reports Q3 Results Amid Market Challenges, Stock Near 52-Week Low (SNDL)

GuruFocus report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST marketscreener.com • 21h ago

SNDL Inc. 's Board intends to launch an Equity Buyback.

marketscreener.com report covering SNDL Inc. (SNDL) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

SNDL Bull vs. Bear Conversation Board — What's Your Call at $1.24?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON SNDL 🐻 50% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $1.40 (+7.7%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is SNDL (D • RQD 48/100) a Buy at $1.30?

Welcome to the SNDL (SNDL Inc.) Roar Pit. Current RQD Composite is 48/100 (Roarable Sell — Underperform / Distribution Warning) in Medicinal Chemicals and Botanical Products. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

SK SkepticalCFA Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $1.07 (-17.7%)

Spot @ $1.30

Pump the brakes on SNDL — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on SNDL, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless SNDL Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

SI SiliconVal_Bull Verified K Arena Trader 🐂 BULLISH 🎯 Target: $1.64 (+26.2%)

Spot @ $1.30

SNDL cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on SNDL, the market is fixating on short-term headline noise in Medicinal Chemicals and Botanical Products and ignoring the balance sheet and cash flow trajectory. At $1.30 (52-wk range $1.13 - $2.34), any beat on forward guidance forces shorts and underweight funds to chase.